Viewing Study NCT00237250


Ignite Creation Date: 2025-12-24 @ 5:15 PM
Ignite Modification Date: 2025-12-28 @ 5:01 PM
Study NCT ID: NCT00237250
Status: COMPLETED
Last Update Posted: 2012-05-07
First Post: 2005-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose Tolerance
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module